Atrial Fibrillation Devices Market to hit $12.5 Billion by 2025: Global Market Insights, Inc.

The China atrial fibrillation devices market is projected to register over 17.6% CAGR from 2019 to 2025 owing to rising prevalence of cardiac diseases and growing trends of tobacco intake in millennials.


Selbyville, Delaware, April 22, 2019 (GLOBE NEWSWIRE) --

The U.S. atrial fibrillation market is the largest in the world and projected to expand at a CAGR of 13.9% over the forecast period. During the forecast period, it will continue to grow with steady growth and lead the industry at a global level. Modern healthcare infrastructure, developing hospital sector, growing adoption of novel devices to address severe conditions of patients suffering from atrial fibrillation and growing rate of geriatric population in the country should drive the U.S. atrial fibrillation devices market during the projection years.

Global Atrial Fibrillation Devices Market is expected to surpass USD 12.5 billion by 2025; according to a new research study published by Global Market Insights, Inc. Presence of sophisticated healthcare infrastructure and rising adoption rate of advanced technologies will be the major factors driving market growth. Furthermore, increasing baby boomers across the globe and availability of reimbursement scenario in developed regions will prove to be high market impact rendering factor for propelling the market growth.

Inadequate infrastructure in under-developed and developing regions to support atrial fibrillation procedures is a growth hindering factor. Also, high prices of such devices might hinder adoption rates in various economies across the world. During the estimated timeframe, price constraint will continue to impede the industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3165

The use of atrial fibrillation devices in hospitals is estimated to grow at around 14.2% over the forecast period. Rising popularity of multi-specialty hospitals in developing and developed countries will strongly contribute to greater demand for atrial fibrillation devices in this setting. Moreover, increasing preference of patients for hospital settings over other medical facilities will further augment market growth.

Browse key industry insights spread across 500 pages with 805 market data tables & 30 figures & charts from the report, “Atrial Fibrillation Devices Market By Products (EP Ablation Catheters {Radiofrequency, Laser, Cryoablation, Ultrasound, Microwave}, EP Diagnostic Catheters {Fixed Curve Catheters, Steerable Catheters, Advanced Mapping Catheters}, Mapping and Recording Systems, Cardiac Monitors or Implantable Loop Recorder, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices), By End-use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Poland, Switzerland, Belgium, Czech Republic, Netherlands, Sweden, Hungary, Austria, Portugal, Denmark, Norway, Finland, Ireland, Turkey, China, Japan, India, Australia, South Korea, Taiwan, New Zealand, Singapore, Brazil, Argentina, Venezuela, Columbia, Mexico, South Africa, Saudi Arabia, UAE, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/atrial-fibrillation-devices-market

Cardiac monitors or implantable loop recorder market was valued around USD 807.1 million in the year 2018. Gradual increasing acceptance of cardiac monitors will augment industry growth in forthcoming years. The adoption rate of cardiac monitors is increasing owing to efficient long-term heart rhythm monitoring it offers as compared to other standard Holter monitor or electrocardiogram. Moreover, rising demand for minimally invasive procedures is a major factor augmenting the growth of the market. The growing application of such devices is mainly associated with current technological enhancements including easier implant surgeries, miniaturization and remote nursing, all of it making this approach more promising and appealing. Hence, cardiac monitors or implantable loop recorders have been verified to be a highly effective and safe tool for detecting atrial fibrillation conditions and various atrial perturbations, thus boosting the growth of cardiac monitors or implantable loop recorder market.

Some of the key industry players operating in the global atrial fibrillation market are Abbott Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation, Boston Scientific Corporation, St. Jude medical, Inc., Medtronic Plc, Koninklijke Philips N.V., and Siemens AG. The industry participants emphasize on mergers and acquisitions, new product developments, and geographical expansion to strengthen their foothold in the market and gain competitive advantage over its peers.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3165

Browse Related Reports:

Healthcare Cloud Computing Market By Application (Clinical Information Systems {Health Information System, Telehealth, Picture Archiving & Communication System [PACS], Pharmacy Information Systems, Laboratory Information Management System, Radiology Information Systems, Computerized Physician Order Entry, Ambulatory or Outpatient CIS}, Nonclinical Information Systems {Revenue Cycle Management, Supply Chain Management Solutions}), By Component (Services {Software as a Service [SaaS], Infrastructure as a Service [IaaS], Platform as a Service [PaaS]}, Software), By Deployment (Public Cloud, Private Cloud), End-use (Hospitals, Pharmacies, Diagnostic & Imaging Centers, Ambulatory Centers, Private Payers, Public Payers) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

https://www.gminsights.com/industry-analysis/healthcare-cloud-computing-market

Diabetic Retinopathy Market By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Age Group (40-49, 50-64, 65-74), By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Distribution Channel (Hospitals & Pharmacies, Eye Clinics, Ambulatory Surgical Centers (ASCs)), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


            

Contact Data